Leonteq Securities’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Leonteq Securities's HALO Position: Q3 2026 in Review
Leonteq Securities reduced its Halozyme (HALO) stake by 31% in Q3 2026, selling an estimated $18.8K and leaving 435 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #784.
Leonteq Securities first reported a position in HALO in Q3 2021 and has held it in 16 quarters since. The position peaked at $60.9K in Q2 2022. 650 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- Leonteq Securities held 435 shares of Halozyme worth $48K as of Q3 2026.
- Leonteq Securities sold 195 Halozyme shares in Q3 2026, an estimated $18.8K.
- Halozyme made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #784 holding.
- Leonteq Securities first reported a position in Halozyme in Q3 2021 and has held it in 16 quarters since.
- Leonteq Securities's Halozyme position peaked at $60.9K in Q2 2022.
- 650 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.